OOIR: Observatory of International Research

Papers

(The TQCC of Scandinavian Journal of Immunology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management	192
Pattern of human monocyte subpopulations in health and disease	106
Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms	75
T cell immunobiology and cytokine storm of COVID‐19	73
The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment	55
An inflammation classification system using cytokine parameters	52
Mechanism of fibrosis and stricture formation in Crohn's disease	52
Advances in Neutralization Assays for SARS‐CoV‐2	40
Current knowledge on autoantigens and autoantibodies in psoriasis	37
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID‐19 and its pneumonic superinfection and complicating inflammation?	37
SARS‐CoV‐2 infection‐induced immune responses: Friends or foes?	30
Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19	30
Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy	26
The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: A new therapeutic target?	26
TLR10: Insights, controversies and potential utility as a therapeutic target	25
The role of innate immunity and inflammation in Parkinson´s disease	25
Cold‐inducible RNA‐binding protein (CIRP) in inflammatory diseases: Molecular insights of its associated signalling pathways	25
A comparative review of intelectins	24
Mucosal chemokine CXCL17: What is known and not known	24
Serum levels of soluble programmed death‐1 (sPD‐1) and soluble programmed death ligand 1(sPD‐L1) in systemic lupus erythematosus: Association with activity and severity	23
Overview of anti‐BCMA CAR‐T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma	23
COVID‐19: Risk Factors Associated with Infectivity and Severity	23
Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review	23
Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors	22
Immunodeficiency in cartilage‐hair hypoplasia: Pathogenesis, clinical course and management	21

Natural killer cell–derived extracellular vesicles in cancer therapy	21
B cell class switching in intestinal immunity in health and disease	20
The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy	20
The attentive focus on T cell‐mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo	20
COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges	19
High CD4‐to‐CD8 ratio identifies an at‐risk population susceptible to lethal COVID‐19	18
Are superantigens the cause of cytokine storm and viral sepsis in severe COVID‐19? Observations and hypothesis	18
Involvement of autophagy in MHC class I antigen presentation	18
Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases	17
Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis	17
Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour	17
COVID‐19 and maternal pre‐eclampsia: A synopsis	17
The role of Interleukin‐32 in autoimmunity	16
COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel	16
Antibody combinations for optimized staining of macrophages in human lung tumours	16
Barley beta‐Glucan and Zymosan induce Dectin‐1 and Toll‐like receptor 2 co‐localization and anti‐leishmanial immune response in Leishmania donovani‐infected BALB/c mice	15
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease	15
Protective roles for myeloid cells in neuroinflammation	15
Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell‐based therapeutic approaches	14
Genetic interaction between the non‐homologous end‐joining factors during B and T lymphocyte development: In vivo mouse models	14
B cell helper T cells and type 1 diabetes	14
A review of the immune response stimulated by xenogenic tissue heart valves	14
Immunogenetics in systemic lupus erythematosus: Transitioning from genetic associations to cellular effects	14
LncRNA XLOC_003810 promotes T cell activation and inhibits PD‐1/PD‐L1 expression in patients with myasthenia gravis‐related thymoma	14
T follicular regulatory cells: Guardians of the germinal centre?	14
Features and roles of T helper 22 cells in immunological diseases and malignancies	14
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer	13
Dual roles of granzyme B	13
Preoperative TruCulture® whole blood cytokine response predicts post‐operative inflammation in pancreaticoduodenectomy patients—A pilot cohort study	13
IgG‐mediated suppression of antibody responses: Hiding or snatching epitopes?	12
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab	12
Cellular metabolism dictates T cell effector function in health and disease	12
Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis	12
Upregulated microRNA‐132 in T helper 17 cells activates hepatic stellate cells to promote hepatocellular carcinoma cell migration in vitro	12
Approaches to inducing antigen‐specific immune tolerance in allergy and autoimmunity: Focus on antigen‐presenting cells and extracellular vesicles	12
T cell immunoglobulin and mucin domain protein 3 inhibits glycolysis in RAW 264.7 macrophages through Hexokinase 2	11
Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells	11
Expression of TOB/BTG family members in patients with inflammatory bowel disease	11
B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia	11
Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases	11
Adipose‐derived mesenchymal stromal cells suppress osteoclastogenesis and bone erosion in collagen‐induced arthritis	11
Increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: Cross‐sectional study	11
Consequences of maternal psychological stress during pregnancy for the risk of asthma in the offspring	11
Putative role of marginal zone B cells in pathophysiological processes	10
The roles of small‐molecule inflammatory mediators in rheumatoid arthritis	10
Adaptor proteins: Flexible and dynamic modulators of immune cell signalling	10
The immunomodulatory potentials of interleukin‐27 in airway allergies	10
Perforin, COVID‐19 and a possible pathogenic auto‐inflammatory feedback loop	10
Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India	10
An increase in CD62L^dim neutrophils precedes the development of pulmonary embolisms in COVID‐19 patients	9

Coronavirus infection: An immunologists' perspective	9
Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour‐infiltrating lymphocytes	9
Innate lymphoid cells in colorectal cancer	9
Diagnostic and therapeutic caveats in Griscelli syndrome	9
Fungal recognition by mammalian fibrinogen‐related proteins	9
Early humoral defence: Contributing to confining COVID‐19 to conducting airways?	9
Serum‐soluble PD‐L1 may be a potential diagnostic biomarker in sepsis	9
Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis‐mediated bone loss	9
The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions	8
Profiling the pattern of human TRB/IGH‐CDR3 repertoire in liver transplantation patients via high‐throughput sequencing analysis	8
Gastrointestinal and renal complications in SARS‐CoV‐2‐infected patients: Role of immune system	8
Toll‐like receptor‐2/7‐mediated T cell activation: An innate potential to augment CD8⁺ T cell cytokine production	8
IL‐6 alters migration capacity of CD4⁺Foxp3⁺ regulatory T cells in systemic lupus erythematosus	8
Role of the antigen presentation process in the immunization mechanism of the genetic vaccines against COVID‐19 and the need for biodistribution evaluations	8
Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009‐2018)	8
Insights into the toll‐like receptors in sexually transmitted infections	8
Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)	8
The role of the cholinergic anti‐inflammatory pathway in autoimmune rheumatic diseases	8
Correlation of myeloid‐derived suppressor cells with C‐reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID‐19	8
Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: A single‐centre study	8
Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre‐ and post‐transplantation cytokine responses in stimulated whole blood	8
Rational harm‐benefit assessments by age group are required for continued COVID‐19 vaccination	8
Immunobiology and conflicting roles of the human CD161 receptor in T cells	7
Decreased neutrophil‐mediated bacterial killing in COVID‐19 patients	7
CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis	7
Immune and stromal related genes in colon cancer: Analysis of tumour microenvironment based on the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases	7
Association of reduced maternal sHLA‐G5 isoform levels and elevated TNF‐α/IL‐4 cytokine ratio with Recurrent Pregnancy Loss: A study on South Indian women	7
An explanation of the pathogenesis of several autoimmune diseases in immuno‐compromised individuals	7
T cell receptor therapy against melanoma—Immunotherapy for the future?	7
Interleukin 4 deficiency limits the development of a lupus‐like disease in mice triggered by phospholipids in a non‐bilayer arrangement	7
Prognostic value and predictive biomarkers of phenotypes of tumour‐associated macrophages in colorectal cancer	7
Disease mechanisms in Sjögren’s syndrome: What do we know?	7
A review on the interactions between dendritic cells, filarial parasite and parasite‐derived molecules in regulating the host immune responses	7
Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects	7
Severe COVID‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils	6
Bioinformatics analysis of gene expression profiles of Inclusion body myositis	6
Physiological levels of 25‐hydroxyvitamin D₃ induce a suppressive CD4⁺ T cell phenotype not reflected in the epigenetic landscape	6
Lipopolysaccharide‐responsive beige‐like anchor acts as a cAMP‐dependent protein kinase anchoring protein in B cells	6
Myeloid‐derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma	6
Chrysin enhances antitumour immunity response through the IL‐12‐STAT4 signal pathway in the B16F10 melanoma mouse model	6
The historical postulate: Is it the basis, at the level of the system, for self‐nonself discrimination?	6
The neonatal Fc receptor in mucosal immune regulation	6
Non‐tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade‐off and NTM ways into virulence	6
Upregulation of the expression of Toll‐like receptor 9 in basophils in patients with allergic rhinitis: An enhanced expression by allergens	6
Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection	6
The cytokine storm—An appropriate, over‐reactive response to SARS‐CoV‐2 or the wrong immune pathway?	6
Gut tissue‐resident memory T cells in coeliac disease	6
IL‐16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity	6
Zinc homeostasis in immunity and its association with preterm births	6
The effect of BCG vaccine in the era of COVID‐19 pandemic	6
The role of cytokines in determining the Th1/Th2 phenotype of an immune response: Coherence of the T cell response and the Cytokine Implementation Hypothesis	6
The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases	6
Regulation of thymic T regulatory cell differentiation by TECs in health and disease	5
The blood protein hCAP‐18 in neutropenia: An 18‐month experience of a new ELISA for clinical use	5
Interferons and innate immune activation in autoimmune congenital heart block	5
Saturated fatty acids activate the inflammatory signalling pathway in Schwann cells: Implication in sciatic nerve injury	5
SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy	5
Novel vaccine design based on genomics data analysis: A review	5
Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients	5
Advances in CD247	5
Microbial sensing by haematopoietic stem and progenitor cells: Vigilance against infections and immune education of myeloid cells	5
Can interruption/withdrawl of anti‐retroviral therapy provide personalized immunotherapy against HIV‐1?	5
Aicardi–Goutières syndrome: A monogenic type I interferonopathy	5
Cellular scars and local crosstalk in relapsing psoriasis: an example of a skin sticking disease	5
Partial albinism and immunodeficiency in patients with Hermansky‐Pudlak Type II: Introducing 2 novel mutations	5
Waiting in the wings: RUNX3 reveals hidden depths of immune regulation with potential implications for inflammatory bowel disease	5